Boston Scientific Contour SE Uterine Fibroid Treatment Launch Commences
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific is supporting the launch of its Contour SE embolic agent for uterine fibroid treatment with trial data showing that embolized patients returned to work three times sooner than those treated with myomectomy